Total Payments
$518,391
2024 Payments
$60,799
Companies
34
Transactions
925
Medicare Patients
2,138
Medicare Billing
$140,729
Payment Breakdown by Category
Consulting$297,727 (57.4%)
Other$171,944 (33.2%)
Travel$34,186 (6.6%)
Food & Beverage$13,263 (2.6%)
Research$1,272 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $297,727 | 538 | 57.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $156,626 | 58 | 30.2% |
| Travel and Lodging | $34,186 | 79 | 6.6% |
| Food and Beverage | $13,263 | 236 | 2.6% |
| Honoraria | $10,605 | 8 | 2.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,713 | 2 | 0.9% |
| Unspecified | $1,272 | 4 | 0.2% |
Payments by Type
General
$517,120
921 transactions
Research
$1,272
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $133,730 | 224 | $0 (2024) |
| Edwards Lifesciences Corporation | $100,524 | 347 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $81,158 | 76 | $0 (2023) |
| Gilead Sciences, Inc. | $50,680 | 58 | $0 (2018) |
| GE HEALTHCARE | $49,982 | 19 | $0 (2024) |
| Chiesi USA, Inc. | $42,432 | 41 | $0 (2023) |
| Abbott Laboratories | $30,144 | 55 | $0 (2024) |
| PROCYRION, INC. | $18,638 | 4 | $0 (2024) |
| Medtronic, Inc. | $3,328 | 20 | $0 (2024) |
| ABIOMED | $2,717 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60,799 | 153 | Edwards Lifesciences Corporation ($34,522) |
| 2023 | $83,984 | 149 | GE HealthCare ($34,027) |
| 2022 | $89,184 | 152 | Janssen Pharmaceuticals, Inc ($29,851) |
| 2021 | $65,610 | 139 | Janssen Pharmaceuticals, Inc ($20,982) |
| 2020 | $47,556 | 81 | Boston Scientific Corporation ($26,098) |
| 2019 | $53,571 | 84 | Boston Scientific Corporation ($25,339) |
| 2018 | $45,666 | 74 | BOSTON SCIENTIFIC CORPORATION ($18,874) |
| 2017 | $72,023 | 93 | Gilead Sciences Inc ($46,298) |
All Payment Transactions
925 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | AMPLATZER (Device) | Food and Beverage | In-kind items and services | $149.22 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | AngioDynamics, Inc. | ALPHAVAC (Device) | Food and Beverage | In-kind items and services | $52.06 | General |
| Category: VIT | ||||||
| 12/11/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $471.75 | General |
| 12/11/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $404.58 | General |
| 12/11/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $323.67 | General |
| 12/04/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $539.06 | General |
| 12/04/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $396.68 | General |
| 12/04/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $264.26 | General |
| 11/22/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $715.65 | General |
| 11/22/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $385.24 | General |
| 11/22/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $55.04 | General |
| 11/22/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $44.07 | General |
| 11/20/2024 | AngioDynamics, Inc. | ALPHAVAC (Device) | Food and Beverage | In-kind items and services | $61.53 | General |
| Category: VIT | ||||||
| 11/07/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Travel and Lodging | In-kind items and services | $426.03 | General |
| Category: Structural Heart | ||||||
| 11/07/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Travel and Lodging | In-kind items and services | $355.26 | General |
| Category: Structural Heart | ||||||
| 11/07/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Travel and Lodging | In-kind items and services | $346.76 | General |
| Category: Structural Heart | ||||||
| 11/07/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Travel and Lodging | In-kind items and services | $289.80 | General |
| Category: Structural Heart | ||||||
| 11/07/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Travel and Lodging | In-kind items and services | $289.80 | General |
| Category: Structural Heart | ||||||
| 11/07/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Travel and Lodging | In-kind items and services | $258.10 | General |
| Category: Structural Heart | ||||||
| 11/07/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $86.77 | General |
| Category: Structural Heart | ||||||
| 11/07/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $75.92 | General |
| Category: Structural Heart | ||||||
| 11/07/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Structural Heart | ||||||
| 11/06/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $923.03 | General |
| 11/06/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $184.88 | General |
| 11/06/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $92.09 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RIC14 | Roche Diagnostics Operations, Inc. | $1,000 | 1 |
| impella | ABIOMED | $143.23 | 1 |
| DTU Pivotal | ABIOMED | $128.42 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 671 | 841 | $421,134 | $47,497 |
| 2022 | 9 | 463 | 568 | $243,935 | $29,068 |
| 2021 | 7 | 653 | 826 | $144,115 | $34,640 |
| 2020 | 10 | 351 | 409 | $131,276 | $29,524 |
Total Patients
2,138
Total Services
2,644
Medicare Billing
$140,729
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93505 | Biopsy of heart muscle | Facility | 2023 | 27 | 49 | $107,293 | $8,783 | 8.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 16 | 18 | $36,306 | $8,167 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 50 | 56 | $21,340 | $4,290 | 20.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $65,750 | $3,893 | 5.9% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 24 | 24 | $72,024 | $3,819 | 5.3% |
| 93456 | Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $56,354 | $3,617 | 6.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 378 | 481 | $13,468 | $3,279 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 45 | 47 | $12,656 | $2,629 | 20.8% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 22 | 27 | $14,133 | $2,365 | 16.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 31 | $6,434 | $2,077 | 32.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 16 | $4,787 | $1,413 | 29.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 30 | $3,379 | $1,214 | 35.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 15 | 16 | $4,675 | $1,122 | 24.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 12 | $2,536 | $828.60 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 71 | 91 | $34,170 | $6,706 | 19.6% |
| 93505 | Biopsy of heart muscle | Facility | 2022 | 22 | 29 | $59,178 | $5,600 | 9.5% |
| 93456 | Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 18 | 19 | $63,309 | $4,628 | 7.3% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 17 | 17 | $46,655 | $2,939 | 6.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 266 | 338 | $8,597 | $2,397 | 27.9% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 20 | 20 | $12,511 | $2,200 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 18 | 18 | $9,136 | $2,022 | 22.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 20 | $6,071 | $1,694 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 16 | 16 | $4,308 | $880.50 | 20.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 80 | 125 | $44,750 | $10,364 | 23.2% |
| 92928 | Catheter placement of stents in major coronary artery or branch, accessed through the skin, each additional artery or branch | Facility | 2021 | 11 | 11 | $22,187 | $5,392 | 24.3% |
About Dr. Carey Kimmelstiel, MD
Dr. Carey Kimmelstiel, MD is a Cardiovascular Disease healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043326713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carey Kimmelstiel, MD has received a total of $518,391 in payments from pharmaceutical and medical device companies, with $60,799 received in 2024. These payments were reported across 925 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($297,727).
As a Medicare-enrolled provider, Kimmelstiel has provided services to 2,138 Medicare beneficiaries, totaling 2,644 services with total Medicare billing of $140,729. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Boston, MA
- Active Since 08/22/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1043326713
Products in Payments
- CLINICAL TRIAL PRODUCT (Device) $93,003
- XARELTO (Drug) $81,158
- Ranexa (Drug) $50,553
- KENGREAL (Drug) $42,432
- AORTIX SYSTEM (Device) $18,638
- AMPLATZER (Device) $14,920
- AMPLATZER Occluders (Device) $7,700
- GENERAL STRUCTURAL HEART (Device) $5,785
- MitraClip System (Device) $5,038
- GENERAL - VASCULAR ACCESS (Device) $4,688
- GENERAL STENTS (Device) $3,185
- GENERAL STENTS (Device) $3,000
- Impella (Device) $2,717
- AMPLATZER TALISMAN (Device) $2,137
- WATCHMAN (Device) $1,464
- GENERAL VASCULAR ACCESS (Device) $1,313
- GENERAL - STENTS (Device) $1,015
- CD cobas Reagents (Device) $1,000
- THERAPIES (Device) $891.57
- CoreValve Evolut (Device) $731.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Boston
Dr. Elizabeth Nabel, M.d, M.D
Cardiovascular Disease — Payments: $3.0M
Cardiovascular Disease $3.0M
Kenneth Rosenfield, M.d, M.D
Cardiovascular Disease — Payments: $1.3M
Cardiovascular Disease $1.3M
Dr. Eric Secemsky, Md, Msc, MD, MSC
Cardiovascular Disease — Payments: $1.3M
Cardiovascular Disease $1.3M
Dr. Benjamin Scirica, M.d, M.D
Cardiovascular Disease — Payments: $1.0M
Cardiovascular Disease $1.0M
Jorge Plutzky, Md, MD
Cardiovascular Disease — Payments: $973,823
Cardiovascular Disease $973,823
Christopher Cannon, Md, MD
Cardiovascular Disease — Payments: $869,405
Cardiovascular Disease $869,405